ASP Isotopes Inc. has announced several updates on the progress of commercial production at its three isotope enrichment facilities in Pretoria, South Africa. The company commenced commercial production of silicon-28 in late March 2025 and has successfully enriched large quantities of intermediate product to 99%, with an annual capacity of greater than 80 kilograms of highly enriched silicon-28. This capacity expansion cost approximately $4 million in fixed asset investment.
Similarly, the company also commenced commercial production of ytterbium-176 in April 2025, achieving an enrichment factor of 52 and expecting to ship commercial samples of enriched ytterbium-176 to customers during August 2025. The ytterbium-176 enrichment plant is currently operating in a batch processing mode but is expected to transition to a semi-continuous commercial processing method in August, increasing production rates exponentially to the targeted production rate of 1 kilogram per annum.
Furthermore, the company has received the first of the required permits to import controlled laser equipment for the enrichment of nickel-64, gadolinium-160, and zinc-68, and is accelerating plans to construct enrichment facilities for these isotopes in South Africa using the QE process.
In terms of carbon-14 and carbon-12, the company experienced delays in the delivery of adequate quantities of feedstock from the customer, which delayed the production of commercial quantities of enriched carbon-14. However, there has been significant interest in carbon-12, and the company is currently enriching carbon-12 to 99.99% in its existing carbon-14 enrichment plant using the ASP technology, expecting to supply its first commercial product during August 2025.
The market has reacted to these announcements by moving the company's shares 16.28% to a price of $9.50. For the full picture, make sure to review ASP Isotopes's 8-K report.
